Naltrexone - Latest Advances

Pharmacological and non-pharmacological treatments for impulsive-compulsive behaviors in Parkinson's disease.

Journal: The Cochrane database of systematic reviews

Published: October 15, 2025

Side effect profile and comparative tolerability of newer generation antidepressants in the acute treatment of major depressive disorder in children and adolescents: protocol for a systematic review and network meta-analysis.

Journal: BMJ open

Published: October 08, 2025

Development of a liquid chromatography-tandem mass spectrometry method for the analysis of plasma naltrexone and its active metabolite in patients with AUD.

Journal: European journal of mass spectrometry (Chichester, England)

Published: October 03, 2025

The NMDAR positive allosteric modulator NYX-783 selectively blocks opioid withdrawal conditioned place aversion in mice.

Journal: bioRxiv : the preprint server for biology

Published: October 03, 2025

Complicated Grief: Is There a Role for Naltrexone?

Journal: The primary care companion for CNS disorders

Published: October 01, 2025

Health Care Professional Willingness to Treat Opioid Use Disorder vs Type 2 Diabetes in Primary Care.

Journal: JAMA network open

Published: September 30, 2025

Aripiprazole or Bupropion Augmentation Versus Switching to Bupropion in Treatment-Resistant Depression: A Risk-Benefit Analysis.

Journal: The Journal of clinical psychiatry

Published: September 26, 2025

Effects of Ethanol and Opioid Receptor Antagonists Naltrexone and LY2444296 on the Organization of Cholesterol- and Sphingomyelin-Enriched Plasma Membrane Domains.

Journal: ACS chemical neuroscience

Published: September 26, 2025

Seeing the bigger picture: endogenous opioids mediate attentional broadening after reward receipt.

Journal: Psychological medicine

Published: September 26, 2025

Long-acting naltrexone restores network connectivity in subjects with co-morbid cannabis and opioid use disorder.

Journal: bioRxiv : the preprint server for biology

Published: September 26, 2025

Exploring drug interactions between newer antidepressants and medications used to treat neurological disorders.

Journal: Expert opinion on drug metabolism & toxicology

Published: September 25, 2025

How to advise an ADHD-patient about pregnancy? Exploring hospital psychiatrists' practices

Journal: Tijdschrift voor psychiatrie

Published: September 25, 2025

Filters

Pharmacological and non-pharmacological treatments for impulsive-compulsive behaviors in Parkinson's disease.

Pharmacological and non-pharmacological treatments for impulsive-compulsive behaviors in Parkinson's disease.

Side effect profile and comparative tolerability of newer generation antidepressants in the acute treatment of major depressive disorder in children and adolescents: protocol for a systematic review and network meta-analysis.

Side effect profile and comparative tolerability of newer generation antidepressants in the acute treatment of major depressive disorder in children and adolescents: protocol for a systematic review and network meta-analysis.

Development of a liquid chromatography-tandem mass spectrometry method for the analysis of plasma naltrexone and its active metabolite in patients with AUD.

Development of a liquid chromatography-tandem mass spectrometry method for the analysis of plasma naltrexone and its active metabolite in patients with AUD.

The NMDAR positive allosteric modulator NYX-783 selectively blocks opioid withdrawal conditioned place aversion in mice.

The NMDAR positive allosteric modulator NYX-783 selectively blocks opioid withdrawal conditioned place aversion in mice.

Complicated Grief: Is There a Role for Naltrexone?

Complicated Grief: Is There a Role for Naltrexone?

Health Care Professional Willingness to Treat Opioid Use Disorder vs Type 2 Diabetes in Primary Care.

Health Care Professional Willingness to Treat Opioid Use Disorder vs Type 2 Diabetes in Primary Care.

Aripiprazole or Bupropion Augmentation Versus Switching to Bupropion in Treatment-Resistant Depression: A Risk-Benefit Analysis.

Aripiprazole or Bupropion Augmentation Versus Switching to Bupropion in Treatment-Resistant Depression: A Risk-Benefit Analysis.

Effects of Ethanol and Opioid Receptor Antagonists Naltrexone and LY2444296 on the Organization of Cholesterol- and Sphingomyelin-Enriched Plasma Membrane Domains.

Effects of Ethanol and Opioid Receptor Antagonists Naltrexone and LY2444296 on the Organization of Cholesterol- and Sphingomyelin-Enriched Plasma Membrane Domains.

Seeing the bigger picture: endogenous opioids mediate attentional broadening after reward receipt.

Seeing the bigger picture: endogenous opioids mediate attentional broadening after reward receipt.

Long-acting naltrexone restores network connectivity in subjects with co-morbid cannabis and opioid use disorder.

Long-acting naltrexone restores network connectivity in subjects with co-morbid cannabis and opioid use disorder.

Exploring drug interactions between newer antidepressants and medications used to treat neurological disorders.

Exploring drug interactions between newer antidepressants and medications used to treat neurological disorders.

How to advise an ADHD-patient about pregnancy? Exploring hospital psychiatrists' practices

How to advise an ADHD-patient about pregnancy? Exploring hospital psychiatrists' practices